The US has approved lenacapavir for HIV prevention. However, experts worry that cuts to the health budget will "squander" the drug's chance of reducing infections.

The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...

Discover how young healthcare innovators from Durban are transforming clinical trials and community health, earning accolades ...

Lenacapavir, created by Foster City-based Gilead Sciences, has been in use for several years as a treatment for HIV/AIDS ...

In 2023, a clinical trial began in South Africa and the US to test the efficacy of a potential vaccine against HIV called VIR-1388. Like other vaccines, VIR-1388 would not be a cure for HIV but, if it ...

Last week the US Food and Drug Administration approved Gilead Sciences Yeztugo (lenacapavir) for the prevention of HIV ...

A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much ...

In a bold step toward global health justice, Ugandan biotech company DEI BioPharma has announced it will begin manufacturing ...

A twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by ...

Health-care experts and advocates say Gilead's HIV prevention shot could be a "wonder drug," but there is concerns about accessiblity.